Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Not selected

Reason for decision:

Not eligible for Health Technology Evaluation guidance

Rationale:

Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. Traditional approaches to cost-effectiveness analysis, as used in TA, are not appropriate for antimicrobials. New antimicrobials will now be considered for NICE evaluation as part of NHS England’s Antimicrobial Products Subscription Model. Therefore, an evaluation of this product would not be appropriate.

ID number:

12035

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation